Celemics셀레믹스
331920 · KOSDAQ · ₩331920 · 셀레믹스
₩9,230▲ ₩10 (0.11%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 42.8% | 49.7% | 54.7% | 23.1% | 27.8% | 35.1% |
| Operating margin | −74.4% | −57.6% | −28.3% | −87.7% | −65.7% | −74.0% |
| Net margin | −194.8% | −70.0% | 182.6% | −58.9% | −55.0% | −64.8% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −9.5% | −14.2% | +2.1% | −24.6% | +8.0% | — |
| Operating income growth | −16.8% | −74.7% | +67.0% | −0.6% | +4.1% | — |
| Net income growth | −151.9% | −132.9% | +416.5% | +19.2% | +8.4% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −38.1% | −16.1% | 57.0% | −22.5% | −22.9% | −22.4% |
| Return on assets | −17.4% | −15.0% | 51.6% | −19.2% | −19.5% | −19.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 60.5% | 6.0% | 8.2% | 14.1% | 19.5% | 15.0% |
| Net debt to equity | −68.6% | −12.3% | −12.7% | −10.8% | −5.5% | −25.6% |
| Current ratio | 2,291.8% | 658.1% | 611.3% | 770.6% | 590.3% | 1,134.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Celemics / 셀레믹스 / 331920 / KRX:331920
Source: KRX statistical information